Features
Liz Lewis, Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology, discusses the importance and challenges of making the...
With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) of global law...
When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the EU. With services already...
Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite the best efforts of UK...
In June 2019, Pharmafocus visited the headquarters of cannabis company Canopy Growth in the Canadian town of Smiths Falls. Louis Goss...
Israel-based Kanabo Research is one of many emerging firms leading the international surge of research and development into the potential of...
In the first of three articles on the topic, Callum McGuinn, Associate and European Patent Attorney at Mewburn Ellis, explores the history of...
Pharmafocus spoke to head figures from three of the Alliance’s founding partners to get a feel for how it will operate, how it will deliver on...
Patrick Connor, VP and Global Franchise Head, Tumor Drivers and Resistance Mechanisms, at AstraZeneca, discusses his company’s role in the Lung...
On 24 September, the United Nations convened in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s Global Head of Pharma...